Truist lowered the firm’s price target on Integral Ad Science to $17 from $26 but keeps a Buy rating on the shares. The company reported “strong” Q4 results but guided softer Q1 and FY24 due to pricing concessions to a number of Measurement clients, which should pressure growth in the first half of the year, the analyst tells investors in a research note. Strength across social, short-form video, connected TV, and international should reaccelerate growth in the second half however, the firm added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on IAS:
- IAS Reports Fourth Quarter and Full Year 2023 Financial Results
- Integral Ad expands AI-driven safety and suitability measurement to Meta
- Integral Ad Science initiated with a Buy at BofA, sees long runway for growth
- Integral Ad Science initiated with a Buy at BofA
- ‘2024 Will Be a Breakout Year for AdTech,’ According to BMO — Here Are 3 Stocks to Take Advantage